Josep Bassaganya-Riera featured in VTCRC series

November 3, 2016 Blacksburg, VA—NIMML director Josep Bassaganya-Riera gave his perspective on his values and the lessons he has learned as the founder of BioTherapeutics to the Virginia Tech Corporate Research Center Business Brief series.

“My resolve—among many other things—is to build a company relying on innovative technologies and accelerated product development while committing to Virginia’s “Top 3 by 2023” biotech goal and to the Biotech Capital Region branding efforts. My family and I have lived here for many years, and we are quite attached to the solid and ancient beauty of the Appalachian Mountains, as well as the robust community located in the Virginia Tech Corporate Research Center.”

Read the full article here.

About NIMML

The NIMML Institute is a 501 (c) (3) non-profit public charity foundation focused on a transdisciplinary, team-science approach to precision medicine at the interface of immunology, inflammation, and metabolism. The NIMML Institute team has led numerous large-scale transdisciplinary projects and is dedicated to solving important societal problems by combining the expertise of immunologists, computational biologists, toxicologists, modelers, translational researchers, and molecular biologists. The Institute is headquartered in Blacksburg, VA. For more information, please visit www.nimml.org or contact pio@nimml.org.